Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Xaralambos Zervos, DO

954.659.5133

Xaralambos Zervos, DO
Department: Transplantation Center
Medical Director of Liver Transplant
Location: Florida, Weston
Mail Code Weston Clinic
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:954.659.5133
WorkFax:954.659.6731
Surgeon:
No
Type of Doctor:
Adults Only

Education & Fellowships

Fellowship - University of Miami School of Medicine - Jackson Memorial Hospital
Gastroenterology
Miami, FL USA
2011
Fellowship - University of Miami School of Medicine - Jackson Memorial Hospital
Hepatology
Miami, FL USA
2008
Residency - Mount Sinai Medical Center
Internal Medicine
Miami Beach, FL USA
2007
Residency - UPMC Mercy Hospital of Pittsburgh
Internal Medicine
Pittsburgh, PA USA
2006
Internship - UPMC Mercy Hospital of Pittsburgh
Pittsburgh, PA USA
2005
Medical School - Nova Southeastern College of Osteopathic Medicine
Ft. Lauderdale, FL USA
2004
Undergraduate - Barry University
Masters in Science
Miami Shores, FL USA
1999

Certifications

  • Internal Medicine (AOA)
  • Internal Medicine (AOA)- Gastroenterology
  • Internal Medicine (AOA)- Transplant Hepatology

Treatment & Services

  • Abdominal Surgery
  • Abnormal Liver Imaging
  • Abnormal Liver Tests
  • Advanced Laparoscopic Surgery
  • Bile Duct Exploration
  • Biliary Surgery
  • Care of Liver Transplant Patients
  • Department of General Surgery
  • Evaluation of Hepatobiliary Malignancies
  • General Surgery
  • Hepatobiliary Surgery
  • Hepatobiliary Transplantation
  • Laparoscopic Liver Resection
  • Laparoscopic Liver Surgery
  • Laparoscopic Treatment of Liver Cysts
  • Liver Resection
  • Liver Surgery
  • Liver Transplant
  • Liver Transplantation
  • Liver Tumor Clinic
  • Management of Hepatobiliary Malignancies
  • Organ Transplantation
  • Pre-Transplant Evaluation
  • Renal Autotransplantation
  • Reoperative Abdominal Surgery
  • Solid Organ Transplant
  • Transplantation

Specialty in Diseases and Conditions

  • Abnormal Liver Imaging
  • Adenoma of the Liver
  • Alagilles Syndrome
  • Alcohol and Alcohol Hepatitis
  • Alpha-1 Antitrypsin Deficiency
  • Amebic Liver Abscess
  • Angiosarcoma of the Liver
  • Ascites
  • Autoimmune Chronic Hepatitis
  • Autoimmune Hepatitis
  • Benign Tumors of the Liver
  • Bile Leak
  • Biliary Atresia
  • Biliary Stricture
  • Budd Chiari
  • Carcinoid Syndrome
  • Caroli Disease/Syndrome
  • Cholangiocarcinoma
  • Choledochal Cysts
  • Cirrhosis
  • Congenital Hepatic Fibrosis
  • Congestive Hepatopathy
  • Diseases of the Liver Biliary Tract and Pancreas
  • Drug Hepatitis
  • Familial Amyloidosis
  • Fatty Liver Disease
  • Fibrolamellar
  • Fibroma of the Liver
  • Focal Nodular Hyperplasia
  • Gilbert's Syndrome
  • Glycogen Storage Disease
  • Hemangiomas
  • Hemochromatosis
  • Hepatic Encephalopathy
  • Hepatic Outlet Obstruction
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Hepatitis D (HDV)
  • Hepatitis E (HDV)
  • Hepatitis G (HDV)
  • Hepatocellular Carcinoma
  • Hepatoma
  • Hepatomegaly
  • Hepatopulmonary Syndrome
  • Hepatorenal Syndrome
  • Hepatosplenomegaly
  • Hepatotoxicity
  • Leiomyoma of the Liver
  • Lipoma
  • Liver Cancer
  • Liver Cyst
  • Liver Disease
  • Liver Disease in Pregnancy
  • Liver Failure
  • Liver Fibrosis
  • Liver Tumors
  • Nodular Regenerative Hyperplasia
  • Non-alcoholic Steatohepatitis (NASH)
  • Peliosis Hepatis
  • Polycystic Liver Disease
  • Porphyria
  • Portal Hypertension
  • Portal Vein Thrombosis
  • Primary Biliary Cirrhosis
  • Primary Oxalosis
  • Primary Sclerosing Cholangitis
  • Progressive Familial Intrahepatic Cholestasis
  • Sarcoidosis
  • Wilson Disease

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/31/2016, Dr. Zervos has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Zervos receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • AbbVie, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Greek

Patient Satisfaction Reviews

Learn About Our Survey

Criteria

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.